Abstract. The peritumoral stroma and cancer-associated fibroblasts (CAFs) have been suggested to play an important role in breast tumorigenesis. The specific immunohistochemical characteristics of the stromal component according to the breast carcinoma subtype surrogates of molecular classes is poorly understood. In the present study, immunohistochemical staining was used to evaluate the expression of matrix metalloproteinase 2 (MMP2), which is one of the most important proteins considered to facilitate tumor invasion, in a series of invasive breast carcinomas according to subtype: Luminal A, luminal B, luminal-HER2, HER2-enriched and triple-negative. A significant increase in MMP2 expression was demonstrated in tumors known to exhibit a more aggressive metastatic behavior, such as luminal HER2 (37%), HER2-enriched (30%) and triple-negative tumors (17%), compared with the luminal A (6%) or luminal B (13%) subtypes. Our data indicated that the CAFs associated with different breast subtypes exhibit different specific properties to facilitate tumor invasion.
Introduction
Over several years, the majority of studies on breast carcinoma have focused only on the epithelial component; however, the tumor-associated stroma and particularly the cancer-associated fibroblasts (CAFs) have been found to play a crucial role in cancer pathogenesis (1, 2) .
We previously demonstrated that the majority of these CAFs were smooth muscle actin (SMA)-positive, with a myofibroblastic-like phenotype, and that the presence of these peritumoral myofibroblasts (PMYs) is crucial for in situ and invasive breast carcinoma of no special type (NST), as well in metastatic disease (3, 4) . The origin of PMYs remains debatable, but we previously demonstrated that the resident CD34-positive breast fibroblasts are able to acquire SMA myofibroblastic characteristics under the control of the transforming growth factor β-1 pathway (3). It was suggested that these PMYs promote tumor invasion, growth and angiogenesis through paracrine factors and̸or direct cell-cell crosstalk (5). Therefore, it was suggested that CAFs̸PMYs potentially secrete various proteins, particularly matrix metalloproteinase 2 (MMP2), to facilitate tumor invasion (6, 7) . To elucidate this issue, we immunohistochemically analyzed the expression of MMP2 in normal breast stromal fibroblasts and in CAFs̸PMYs present in invasive breast carcinoma of NST, according to clinicopathological variables. Our data were reviewed according to the highlights of the recent literature. Immunostaining for MMP2 (clone 17B11, dilution 1:30; Leica Microsystems GmbH) was performed using a fully automated immunohistochemical system (Autostainer Link A48; Dako, Glostrup, Denmark).
Materials and methods

Specimens
A two-grade system was used to score the stromal expression of MMP2, which was classified as positive or negative according to a cut-off of 10%.
Statistical analysis. The Chi-square or Fisher's exact tests were used to statistically compare the clinicopathological variables described in the Table I. P<0.05 was considered to indicate a statistically significant difference.
Results
Stromal MMP2 expression.
No MMP2 expression was observed in the stroma surrounding normal breast acini or ductal units (Fig. 1) . By contrast, MMP2 expression was present in the peritumoral stroma in 24 of the 155 cases (15%) of invasive breast carcinoma (Fig. 1) . According to the different clinical parameters, there was no correlation between MMP2 stromal expression and patient age, histological grade, lymph node involvement, ER/PR positivity, or Ki-67 index. Conversely, MMP2 stromal expression was statisti-statistically significantly different in tumors sized ≤20 mm (21% positivity) compared with tumors >20 mm (8% positivity) (P= 0.02). In addition, stromal expression in HER2-positive carcinomas was more frequent compared with that in in HER2-negative tumors (35 vs. 12%, respectively; P= 0.002). Finally, according to the subtype immunohistochemical classification surrogates of molecular classes, MMP2 stromal expression appeared more frequently by decreasing order in luminal-HER2 (37%), HER2-enriched (30%), triple-negative (17%), luminal B (13%) and luminal A (6%) tumors (P= 0.025) (Table II) .
Discussion
Several recent studies support the hypothesis that, in invasive breast carcinoma, the gene expression profile of the epithelial component and, therefore, the immunohistochemical profile surrogates of molecular classes, represent biologically distinct diseases with different response to therapy and clinical outcome (12, 13) . In addition to the epithelial cell autonomous processes, it has been hypothesized that the tumor microenvironment, and particularly CAFs, are able to promote tumor cell proliferation, angiogenesis and metastasis (3, 4, 14) . Certain breast CAFs, which are characterized by SMA expression and are referred to as PMYs, appear to play an important role in metastasis, including lymph node metastasis (3, 4) . Therefore, similar to the epithelial counterpart, it was hypothesized that the tumor's aggressiveness may be affected by the stromal composition, as well as the stroma's own biological properties ('stromal signature') (15, 16) . In the present study, we demonstrated that the stromal expression of MMP2, which is known to promote cancer invasion and metastasis by degrading various components of the extracellular matrix, varies according to the different tumor subtypes. In particular, in HER2-positive (luminal-HER2 and HER2-enriched) and triple-negative tumors, stromal expression of MMP2 was more frequently detected compared with the luminal subtypes (Table II) . Of note, it was recently indicated that, on multivariate analysis, luminal-HER2, HER2-enriched and triple-negative tumors are associated with a higher rate of distant metastasis, including brain, liver and lung metastases (13, 17) . Therefore, the metastatic potential may be determined by the intrinsic properties of the epithelial component of the different breast tumor subtypes, as well as by the stromal properties of the microenvironment, as in the present case, by expressing different MMP2 levels, which have been implicated in the degradation of extracellular matrix and the enhancement of tumor cell motility (7, (18) (19) (20) . In conclusion, different stromal properties, such as MMP2 expression, may predispose the different histological breast tumor subtypes to different metastatic outcomes. Further studies are in progress, with the aim to accurately characterize stromal properties based on breast cancer subtype classification. MMP2 expression, no. 
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